Application of Powdered Vancomycin in the Surgical Wound in Haiti

PHASE4CompletedINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

October 10, 2019

Primary Completion Date

October 10, 2021

Study Completion Date

April 5, 2022

Conditions
Surgical Site Infection
Interventions
DRUG

application of powdered vancomycin in the surgical wound as prophylaxis against the occurrence of surgical site infection

on the application of powdered vancomycin in the surgical wound as prophylaxis against the occurrence of surgical site infection at La Paix State University Hospital Haiti over 2 years.Both groups benefited from the same preoperative asepsis protocol. One hour before the incision, 1g of intravenous ceftriaxone is administered to the patients, this dose is maintained during the 48 hours postoperative every 12 hours. At discharged the two groups of patients received oral cloxacilin 500mg three times a day for one week. Patients are dressed every 2 days until the surgical wound has healed. Patients are seen in the outpatient clinic at 2, 4, and 6 weeks, then at one year. We selected 215 patients and retained 204.

Trial Locations (1)

ht6144

Cliniques Orthos, Port-au-Prince

All Listed Sponsors
lead

Clinique Ortos

OTHER

NCT05535725 - Application of Powdered Vancomycin in the Surgical Wound in Haiti | Biotech Hunter | Biotech Hunter